1998
DOI: 10.1016/s0016-5085(98)83900-0
|View full text |Cite
|
Sign up to set email alerts
|

Intestinal absorption of saquinavir in the rat: Insights in possible mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2007
2007

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The effect of specific modulators of P-gp and/or CYP, such as verapamil, ketoconazole and cyclosporine, on increasing intestinal permeability of saquinavir has been demonstrated in vitro in Caco 2 cell lines (5). Furthermore, a number of in situ/in vivo studies have demonstrated the effect of inhibition of Pgp/CYP like processes on increasing portal and systemic blood levels of saquinavir (9,17). To this end, saquinavir therapy is now generally recommended in combination with another protease inhibitor, ritonavir, primarily on the basis of a favorable pharmacokinetic interaction (i.e.…”
Section: Introductionmentioning
confidence: 99%
“…The effect of specific modulators of P-gp and/or CYP, such as verapamil, ketoconazole and cyclosporine, on increasing intestinal permeability of saquinavir has been demonstrated in vitro in Caco 2 cell lines (5). Furthermore, a number of in situ/in vivo studies have demonstrated the effect of inhibition of Pgp/CYP like processes on increasing portal and systemic blood levels of saquinavir (9,17). To this end, saquinavir therapy is now generally recommended in combination with another protease inhibitor, ritonavir, primarily on the basis of a favorable pharmacokinetic interaction (i.e.…”
Section: Introductionmentioning
confidence: 99%